
1. malar j. 2015 feb 5;14:50. doi: 10.1186/s12936-015-0577-7.

fast track antibody v-gene rescue, recombinant expression plants and
characterization pfmsp4-specific antibody.

kapelski s(1)(2)(3), boes a(4), spiegel h(5), de almeida m(6)(7), klockenbring
t(8), reimann a(9), fischer r(10)(11), barth s(12)(13), fendel r(14)(15)(16).

author information: 
(1)fraunhofer institute molecular biology applied ecology ime,
forckenbeckstraße 6, 52074, aachen, germany.
stephanie.kapelski@ime.fraunhofer.de.
(2)rwth aachen university, institute molecular biotechnology, worringer weg
1, 52074, aachen, germany. stephanie.kapelski@ime.fraunhofer.de.
(3)institute applied medical engineering rwth aachen university and
hospital, department experimental medicine immunotherapy, pauwelsstraße
20, 52074, aachen, germany. stephanie.kapelski@ime.fraunhofer.de.
(4)fraunhofer institute molecular biology applied ecology ime,
forckenbeckstraße 6, 52074, aachen, germany. alexander.boes@ime.fraunhofer.de.
(5)fraunhofer institute molecular biology applied ecology ime,
forckenbeckstraße 6, 52074, aachen, germany. holger.spiegel@ime.fraunhofer.de.
(6)fraunhofer institute molecular biology applied ecology ime,
forckenbeckstraße 6, 52074, aachen, germany. melanie.almeida@rwth-aachen.de.
(7)rwth aachen university, institute molecular biotechnology, worringer weg
1, 52074, aachen, germany. melanie.almeida@rwth-aachen.de.
(8)fraunhofer institute molecular biology applied ecology ime,
forckenbeckstraße 6, 52074, aachen, germany.
torsten.klockenbring@ime.fraunhofer.de.
(9)fraunhofer institute molecular biology applied ecology ime,
forckenbeckstraße 6, 52074, aachen, germany. andreas.reimann@ime.fraunhofer.de.
(10)fraunhofer institute molecular biology applied ecology ime,
forckenbeckstraße 6, 52074, aachen, germany. rainer.fischer@ime.fraunhofer.de.
(11)rwth aachen university, institute molecular biotechnology, worringer weg 
1, 52074, aachen, germany. rainer.fischer@ime.fraunhofer.de.
(12)fraunhofer institute molecular biology applied ecology ime,
forckenbeckstraße 6, 52074, aachen, germany. stefan.barth@ime.fraunhofer.de.
(13)institute applied medical engineering rwth aachen university and
hospital, department experimental medicine immunotherapy, pauwelsstraße
20, 52074, aachen, germany. stefan.barth@ime.fraunhofer.de.
(14)fraunhofer institute molecular biology applied ecology ime,
forckenbeckstraße 6, 52074, aachen, germany. rolf.fendel@ime.fraunhofer.de.
(15)rwth aachen university, institute molecular biotechnology, worringer weg 
1, 52074, aachen, germany. rolf.fendel@ime.fraunhofer.de.
(16)institute applied medical engineering rwth aachen university and
hospital, department experimental medicine immunotherapy, pauwelsstraße
20, 52074, aachen, germany. rolf.fendel@ime.fraunhofer.de.

background: monoclonal antibodies (mabs) essential tools biological
research, diagnosis therapy, conventionally produced murine
hybridoma cell lines. professional applications mabs depend steady
supply material. hybridoma cultures stop producing antibody or
even die, preservation unique epitope specificity mabs rescue the
sequences encoding antibody variable domains (v regions) important. the
availability sequences enables recombinant expression of
the original antibody applications, opens road antibody
engineering towards innovative diagnostic therapeutic applications. time-
and cost-efficient production system enabling detailed analysis the
antibodies essential requirement context.
methods: sequences rescued three hybridoma cell lines, subjected to
sequence analysis, subcloned binary expression vectors recombinantly
expressed chimeric mab (constant regions human igg1:k1) nicotiana
benthamiana plants. properties recombinant murine mabs were
compared using competition enzyme-linked immunosorbent assay (elisa) surface 
plasmon resonance (spr) spectroscopy. recognition native pfmsp4 the
recombinant mab analysed immunofluorescence staining pf 3d7a schizonts 
and western blot analysis merozoite extract.
results: rescued sequences three hybridoma cell lines identical. 
the recombinant mab successfully expressed igg plants moderate
levels (45 mg/kg fresh leaf weight). preservation original epitope was
demonstrated competition elisa, using recombinant mab three murine
mabs. egf_pfmsp4-specific affinities determined spr spectroscopy 8 nm 
and 10 nm murine recombinant mab, respectively. binding parasite
pfmsp4 confirmed immunofluorescence assay showing characteristic
staining pattern western blot analysis using merozoite extract.
conclusions: demonstrated example egf_pfmsp4-specific antibody,
the described combination simple efficient hybridoma antibody cloning
approach flexible, robust cost-efficient transient expression system
suitable rapidly produce mg-amounts functional recombinant antibodies
provides attractive method generation mabs derivatives as
research tool, novel therapeutics diagnostics.

doi: 10.1186/s12936-015-0577-7 
pmcid: pmc4323031
pmid: 25651860  [indexed medline]

